TITLE

FORMULATION AND EVALUATION OF VORICONAZOLE FLOATING TABLETS

AUTHOR(S)
PARTHIBARAJAN, R.; GOWRISHANKAR, N. L.; RAJITHA, M.; VINAYKUMAR, A.; HIMAVANTHU, M.; RAMESH, K.; VIJAYA, K.
PUB. DATE
July 2012
SOURCE
Asian Journal of Pharmaceutical & Clinical Research;Jul2012, Vol. 5 Issue 3, p180
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The present study involves in the preparation and evaluation of floating tablets of Voriconazole by wet granulation method by using the hydrophilic polymer such as hydroxy propyl methyl cellulose (HPMC K4M) and Carbopol 934 P. Sodium bicarbonate and citric acid were incorporated as gas generating agent. The study aims to achieve extended retention in the stomach which may result in prolonged absorption in proximal part of the small intestine. The prepared tablets were evaluated in terms of thickness, average weight, hardness, friability, drug content uniformity, swelling index, in- vitro buoyancy study and in-vitro dissolution study. The formulated tablet Hardness was found to being the range of 5.5 ?0.42 to 7.0?0.35 kg/cm2, the % friability was in the range of 0.72+ 0.26 to 0.96+ 0.14. In-vitro release studies were carried out using USP XXII dissolution test apparatus. The tablet containing Voriconazole was released from batch F1-F5 found to be 75.12 to 97.2 %. The release of drug from tablets sufficiently sustained for 12 hours by in vitro release study. The lower polymer to drug ratio there was a significant increase in drug release, F2 found to be the best formulation.
ACCESSION #
83260057

 

Related Articles

  • FORMULATION DEVELOPMENT AND EVALUATION OF IN SITU GEL FOR VAGINAL DRUG DELIVERY OF ANTI FUNGAL DRUG. Akhani, Jolly R.; Modi, Chetna D. // Pharma Science Monitor;Apr-Jun2014, Vol. 5 Issue 2, Supp 1, p343 

    The aim of the present study was to formulate and evaluate nystatin containing thermosensitive mucoadhesive gel for vaginal drug delivery to achieve prolonging the residence time, sustained drug release, enhancing efficacy, decreasing recurrence, and increasing patient compliance in the...

  • FORMULATION AND EVALUATION OF EFFERVESCENT FLOATING TABLETS OF ANTI HYPERTENSIVE DRUG. Thesiya, Neeta B.; Shah, Arvind; Bhutt, Chandresh A. // Pharma Science Monitor;Apr-Jun2014, Vol. 5 Issue 2, Supp 1, p313 

    The aim of present investigation is Formulation and Evaluation of Effervescent floating tablets of antihypertensive drug by using HPC-H, sodium bicarbonate and citric acid. Gastric retention systems are such systems, which increase the gastric retention time of the dosage forms at the stomach...

  • FORMULATION, EVALUATION AND OPTIMIZATION OF PRESS COATED PULSATILE TABLET OF ZALTOPROFEN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. Kukadiya, Chetan G.; Desai, Kesha; Swamy, S. M. Vijayendra // Pharma Science Monitor;Apr-Jun2014, Vol. 5 Issue 2, Supp 1, p153 

    The aim of the present study was to formulate, evaluate and optimize press coated pulsatile tablet of Zaltoprofen for the treatment of rheumatoid arthritis. The drug delivery system is based on the concept of chronotherapeutics. Dosage form provide delayed release up to 5 hour and after...

  • Synthesis and Biological Evaluation of Some Novel 3,5-Disubstituted-1,2,4-triazole Incorporated 2-Mercaptobenzothiazoles. Azam, Mohammed Afzal; Suresh, Bhojraj; Srinivas, Naga; Sachdev, Sumit; Rajeshkumar, Raman // Acta Chimica Slovenica;2012, Vol. 59 Issue 4, p739 

    Several 2-mercaptobenzothiazole derivatives 5a-i containing 1,2,4-triazole moiety incorporating two additional substituents were synthesized. All the newly synthesized compounds were tested for in vitro activity against certain strains of bacteria such as Enterococcus faecalis, Bacillus...

  • Selection of excipients for dispersible tablets of itraconazole through the application of thermal techniques and Raman spectroscopy. Wang, Yan; Luo, Yang-Hui; Zhao, Jing; Sun, Bai-Wang // Journal of Thermal Analysis & Calorimetry;Mar2014, Vol. 115 Issue 3, p2391 

    For the development of dispersible tablets of itraconazole (ITR), techniques of thermal, Raman spectroscopy, and isothermal stress testing (IST) were used to assess the compatibility of ITR with selected excipients. Initially, differential scanning calorimeter (DSC) was used to evaluate the...

  • STABILITY STUDIES OF FAST DISPERSIBLE KETOPROFEN 100 mg TABLETS. Zafar, Farya; Shoaib, Muhammad Harris; Yousuf, Rabia Ismail // International Journal of Pharmaceutical Sciences Review & Resear;Mar/Apr2012, Vol. 13 Issue 2, p58 

    In the present study long term testing (12 month) and accelerated testing (6 month) were carried out on fast dispersible Ketoprofen 100 mg tablets in order to assess the physical and chemical stability of Ketoprofen tablets. All the formulations were tested for disintegration test, % drug...

  • Posaconazole. Bhattacharya, M.; Rajeshwari, K.; Dhingra, B. // Journal of Postgraduate Medicine;Apr-Jun2010, Vol. 56 Issue 2, p163 

    Posaconazole is a novel second-generation Triazole oral antifungal agent. It is highly effective in the prophylaxis of invasive fungal infections in immunocompromised patients. It is used as a first-line agent as well as for salvage therapy in invasive fungal infections including aspergillosis,...

  • Formulation and in vitro evaluation of clotrimazole gel containing almond oil and Tween 80 as penetration enhancer for topical application. Nawaz, Asif; Jan, Syed Umer; Khan, Nauman Rahim; Hussain, Abid; Kha, Gul Majid // Pakistan Journal of Pharmaceutical Sciences;May2013, Vol. 26 Issue 3, p617 

    Achieving a desirable percutaneous absorption of drug molecule is a major concern in formulating dermal and transdermal products. The use of penetration enhancers could provide a success till mean for this purpose. The aim of this study was to develop Clotrimazole gel and to evaluate the effect...

  • In Vitro-In Vivo Correlation Evaluation of Generic Alfuzosin Modified Release Tablets. Sanki, Utpal Kumar; Mandal, Badal Kumar // ISRN Toxicology;2012, p1 

    Alfuzosin, a selective alpha-1a antagonistis is the most recently approved AARAS, with limited cardiac toxicity and exclusively used for lower urinary tract syndromes (LUTS). In order to reduce pill burden and better patient compliance modified release (MR) formulations have been developed....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics